Natco Pharma Limited announced that the Board of Directors of the company at its meeting held on November 12, 2014, Mr. P S R K Prasad, Executive Vice President (Corporate Engineering Services) appointed as Additional Director of the company who will be in the whole time employment of the company. Mr. S V V N Appa Rao, Vice President (Finance & Accounts) appointed as Interim (Chief Financial Officer) of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
982.9 INR | -0.71% | -0.21% | +21.14% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.14% | 2.12B | |
+31.17% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.77% | 239B | |
+10.14% | 210B | |
-6.95% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma Limited Announces Management Appointments